Ability of different rescue therapies to save the bowel in acute, severe, steroid-refractory ulcerative colitis

Klaudia Farkas, T. Molnár, Zoltán Szepes

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

To date, corticosteroids have been the primary therapies for acute, severe ulcerative colitis (UC). Patients not responding to intravenous steroids assessed at 3-5 days of the treatment are candidates for second-line rescue therapy. Cyclosporine (CsA), tacrolimus and infliximab (IFX) are also effective therapeutic options in acute, severe UC. In this review we summarized the results of the published studies examining and comparing the efficacy of CsA, tacrolimus and IFX as rescue therapies, and assessing the outcome of switching the drugs in case of therapeutic failure.

Original languageEnglish
Pages (from-to)695-702
Number of pages8
JournalExpert Review of Gastroenterology and Hepatology
Volume8
Issue number6
DOIs
Publication statusPublished - 2014

Fingerprint

Ulcerative Colitis
Steroids
Tacrolimus
Therapeutics
Drug Substitution
Cyclosporine
Adrenal Cortex Hormones

Keywords

  • acute ulcerative colitis
  • cyclosporine
  • infliximab
  • rescue therapy
  • tacrolimus

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology
  • Medicine(all)

Cite this

Ability of different rescue therapies to save the bowel in acute, severe, steroid-refractory ulcerative colitis. / Farkas, Klaudia; Molnár, T.; Szepes, Zoltán.

In: Expert Review of Gastroenterology and Hepatology, Vol. 8, No. 6, 2014, p. 695-702.

Research output: Contribution to journalArticle

@article{f6084239b4244200a34e41ab8133ad3a,
title = "Ability of different rescue therapies to save the bowel in acute, severe, steroid-refractory ulcerative colitis",
abstract = "To date, corticosteroids have been the primary therapies for acute, severe ulcerative colitis (UC). Patients not responding to intravenous steroids assessed at 3-5 days of the treatment are candidates for second-line rescue therapy. Cyclosporine (CsA), tacrolimus and infliximab (IFX) are also effective therapeutic options in acute, severe UC. In this review we summarized the results of the published studies examining and comparing the efficacy of CsA, tacrolimus and IFX as rescue therapies, and assessing the outcome of switching the drugs in case of therapeutic failure.",
keywords = "acute ulcerative colitis, cyclosporine, infliximab, rescue therapy, tacrolimus",
author = "Klaudia Farkas and T. Moln{\'a}r and Zolt{\'a}n Szepes",
year = "2014",
doi = "10.1586/17474124.2014.909726",
language = "English",
volume = "8",
pages = "695--702",
journal = "Expert Review of Gastroenterology and Hepatology",
issn = "1747-4124",
publisher = "Expert Reviews Ltd.",
number = "6",

}

TY - JOUR

T1 - Ability of different rescue therapies to save the bowel in acute, severe, steroid-refractory ulcerative colitis

AU - Farkas, Klaudia

AU - Molnár, T.

AU - Szepes, Zoltán

PY - 2014

Y1 - 2014

N2 - To date, corticosteroids have been the primary therapies for acute, severe ulcerative colitis (UC). Patients not responding to intravenous steroids assessed at 3-5 days of the treatment are candidates for second-line rescue therapy. Cyclosporine (CsA), tacrolimus and infliximab (IFX) are also effective therapeutic options in acute, severe UC. In this review we summarized the results of the published studies examining and comparing the efficacy of CsA, tacrolimus and IFX as rescue therapies, and assessing the outcome of switching the drugs in case of therapeutic failure.

AB - To date, corticosteroids have been the primary therapies for acute, severe ulcerative colitis (UC). Patients not responding to intravenous steroids assessed at 3-5 days of the treatment are candidates for second-line rescue therapy. Cyclosporine (CsA), tacrolimus and infliximab (IFX) are also effective therapeutic options in acute, severe UC. In this review we summarized the results of the published studies examining and comparing the efficacy of CsA, tacrolimus and IFX as rescue therapies, and assessing the outcome of switching the drugs in case of therapeutic failure.

KW - acute ulcerative colitis

KW - cyclosporine

KW - infliximab

KW - rescue therapy

KW - tacrolimus

UR - http://www.scopus.com/inward/record.url?scp=84904466645&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904466645&partnerID=8YFLogxK

U2 - 10.1586/17474124.2014.909726

DO - 10.1586/17474124.2014.909726

M3 - Article

VL - 8

SP - 695

EP - 702

JO - Expert Review of Gastroenterology and Hepatology

JF - Expert Review of Gastroenterology and Hepatology

SN - 1747-4124

IS - 6

ER -